Filing Details
- Accession Number:
- 0001645627-18-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-11 17:04:26
- Reporting Period:
- 2018-12-07
- Accepted Time:
- 2018-12-11 17:04:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 28,200 shares | Avg. Price: $0.02 | Total Value: $671.56 |
| Number of Shares After Transactions: | 26,341,898 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-07 | 2,000 | $0.03 | 26,315,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-07 | 2,000 | $0.03 | 26,317,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-07 | 2,000 | $0.03 | 26,319,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-07 | 1,000 | $0.03 | 26,320,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,321,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,322,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,324,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,326,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,328,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,330,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,332,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,334,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,335,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,336,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 2,000 | $0.02 | 26,338,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 100 | $0.02 | 26,338,798 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,339,798 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 100 | $0.02 | 26,339,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,340,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-10 | 1,000 | $0.02 | 26,341,898 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
